Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index; 3 of the 197 sources its claims cite were checked for support.

Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases

Open access
Mikocka-Walus, Antonina, Knowles, Simon R., Keefer, Laurie, Graff, Lesley · 2016 · Inflammatory Bowel Diseases

Abstract

BACKGROUND: Although mental health concerns are known to occur commonly for those with inflammatory bowel diseases (IBD), the nature of this comorbid relationship has not been systematically reviewed to date. A review in 2007 identified 5 controversies regarding anxiety/depression rates and various comparators between and within IBD. We aimed to systematically analyze and critique the current evidence regarding this comorbidity, providing an update to the 5 controversies. METHODS: Ebscohost Medline, CINAHL, Embase, and PsychINFO were searched between 2005 and 2014 using systematic review methodology. Controlled quantitative studies examining either symptoms or diagnoses of anxiety and depression in IBD were included in the review, with study quality assessed using a scale developed a priori to evaluate observational research. RESULTS: (1) IBD versus healthy controls (pooled mean proportions) (n = 13 studies): anxiety 19.1% versus 9.6%, depression 21.2% versus 13.4%; (2) IBD inactive versus IBD active disease (n = 26): anxiety 28.2% versus 66.4%, depression 19.9% versus 34.7%; (3) ulcerative colitis versus Crohn's disease (n = 28): anxiety 31% versus 37%, depression 22% versus 24.4%; (4) IBD versus other chronic medical conditions (n = 17): anxiety 41.9% versus 48.2%, depression 14.5% versus 28.4%; (5) onset of anxiety/depression before or after IBD onset (n = 2): adults more likely to develop anxiety/depression before IBD onset, but a substantial proportion develops depression after onset; an increased risk for children of developing anxiety/depression after IBD onset. CONCLUSIONS: The high rates of anxiety and depression for those with IBD, particularly when disease is active, warrant a systemic approach to screening and treatment.

Overview

CoChat Summary

## TL;DR

This systematic review updated a 2007 review and found that anxiety and depression are more common in IBD than in healthy controls, are generally higher in active than inactive disease, and are only modestly higher in Crohn’s disease than ulcerative colitis. Evidence for whether anxiety/depression precede or follow IBD onset was limited to 2 studies and suggested anxiety often predates IBD in adults, while children with Crohn’s disease had increased post-diagnosis risk.

## Key findings

  • Across the 5 controversies, the review included 66 unique studies; 4,985 studies were identified initially, 1,264 duplicates were removed, and 210 full papers were reviewed.
  • IBD vs healthy/general population controls: pooled mean anxiety was 19.1% vs 9.6% and pooled mean depression was 21.2% vs 13.4% for IBD vs controls; in the narrative, 7 of 13 anxiety studies and 9 of 13 depression studies reported significantly higher rates/levels in IBD.
  • Active vs inactive IBD: pooled mean anxiety was 66.4% in active disease vs 28.2% in inactive disease; pooled mean depression was 34.7% in active disease vs 19.9% in inactive disease. For anxiety, 11 of 15 studies with comparable data reported significantly higher anxiety in active vs inactive IBD; for depression, 12 of 17 reported significantly higher depression.
  • Crohn’s disease vs ulcerative colitis: pooled mean anxiety was 37% in CD vs 31% in UC, and pooled mean depression was 24.4% in CD vs 22% in UC; only 3 anxiety studies and 2 depression studies found significant subtype differences, all favoring higher burden in CD.
  • IBD vs other medically ill controls: pooled mean anxiety was 41.9% in IBD vs 48.2% in controls, and pooled mean depression was 14.5% in IBD vs 28.4% in controls; the paper notes mixed findings depending on the comparator group.
  • Pre- vs post-IBD onset: only 2 studies addressed this. In adults, 70% with IBD and a lifetime anxiety/mood disorder had first anxiety episode 10+ years before IBD diagnosis, while 8% developed anxiety 2+ years after onset; in children, anxiety incidence was 1.81 vs 0.57 per 100 patient-years and depression incidence 2.69 vs 1.22 per 100 patient-years for IBD vs controls, and Crohn’s disease increased risk of anxiety (HR 2.28; 95% CI 1.65–3.17) and depression (HR 1.74; 95% CI 1.35–2.25).

## Methods

  • Design: Systematic review, registered in PROSPERO (CRD42014014960) and conducted according to PRISMA.
  • Data/sample: Searched Ebscohost Medline, CINAHL, Embase, and PsychINFO in November and December 2014 for peer-reviewed English-language quantitative studies published 2005–2014 on anxiety/depression in IBD; included controlled studies with adult or pediatric samples.
  • Analysis: Two reviewers independently screened and extracted data; quality was appraised with a study-specific scale; the synthesis was narrative, with mean percentages and 95% CIs and weighted means where possible, because heterogeneity limited meta-analysis.

## Limitations

  • The paper states that available studies were largely from Western Europe and North America, with few to none from Eastern Europe, South America, Asia, and Africa; it also states that it could not examine gender differences because virtually no studies reported male/female breakdowns.
  • The paper states that most studies used symptom measures rather than clinical diagnoses, and that there was tremendous variability in measures and cutoffs, which limited cross-study comparability and meta-analysis.
  • Evidence for timing relative to IBD onset was sparse: only 2 of 210 full-text-reviewed studies had applicable data, so conclusions about whether anxiety/depression precede or follow IBD are limited by the review’s own evidence base.

Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1097/mib.0000000000000620

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 1 Not valid · 88 Not checked · 85 Own results and interpretations

72 more claims

Create a free account to see all 176 claims and to verify the 160 references still open.

See all claims — free account
  • It may state two separate claims as one. 61
  • Probably not a substantial claim. 43
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 97 references

Research works printed but not linked: 5

  1. Agostini, 2010, Psychosomatics, 51, 14, 10.1016/s0033-3182(10)70654-x · DOI
  2. Iglesias-Rey, 2014, Inflamm Bowel Dis, 20, 92
  3. Brandi, 2009, Med Sci Monit, 15, PH101
  4. Ghia, 2008, J Clin Invest, 118, 2209
  5. Mikocka-Walus, 2009, 5, 48

Cited by

See all 622

Metadata

Authors
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L.
Affiliations
  • The Royal Melbourne Hospital (AU)
  • Northwestern University (US)
  • University of Manitoba (CA)
Venue
Inflammatory Bowel Diseases
Published
2016-03
Volume
22
Issue
3
Pages
752-762
ISSN
1078-0998 (ISSN-L)
OpenAlex
W2323558841
Cited by
567
References
97
Citations by year
2026: 42 · 2025: 55 · 2024: 53 · 2023: 57 · 2022: 73 · 2021: 96 · 2020: 52 · 2019: 51 · 2018: 41 · 2017: 33 · 2016: 14
FWCI
6.19
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • Own your potential (DEAKIN) (submittedVersion)
  • Figshare (submittedVersion)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
inflammatory bowel disease, anxiety
MeSH terms
Adult, Anxiety, Depression, Humans, Global Health, Inflammatory Bowel Diseases, Comorbidity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. https://app.cochat.ai/papers/10.1097/mib.0000000000000620
The paper
Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016). Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. https://doi.org/10.1097/mib.0000000000000620

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.